Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of a global supportive skin care programme with hydrotherapy after non-metastatic breast cancer treatment: A randomised, controlled study.
Dalenc F, Ribet V, Rossi AB, Guyonnaud J, Bernard-Marty C, de Lafontan B, Salas S, Ranc Royo AL, Sarda C, Levasseur N, Massabeau C, Levecq JM, Dulguerova P, Guerrero D, Sibaud V. Dalenc F, et al. Among authors: de lafontan b. Eur J Cancer Care (Engl). 2018 Jan;27(1). doi: 10.1111/ecc.12735. Epub 2017 Aug 22. Eur J Cancer Care (Engl). 2018. PMID: 28833787 Clinical Trial.
Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
Benchalal M, Le Prisé E, de Lafontan B, Berton-Rigaud D, Belkacemi Y, Romestaing P, Peignaux K, Courdi A, Monnier A, Montcuquet P, Goudier MJ, Marchal C, Chollet P, Abadie-Lacourtoisie S, Datchary J, Veyret C, Kerbrat P. Benchalal M, et al. Among authors: de lafontan b. Cancer. 2005 Jul 15;104(2):240-50. doi: 10.1002/cncr.21161. Cancer. 2005. PMID: 15948160 Free article.
Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients.
Cutuli B, Dhermain F, Borel C, de Larochefordiere A, Graic Y, de Lafontan B, Dilhyudy JM, Mignotte H, Tessier E, Tortochaux J, N'Guyen T, Bey P, Le Mevel-Le Pourhiet A, Velten M, Arriagada R. Cutuli B, et al. Among authors: de lafontan b, de larochefordiere a. Eur J Cancer. 1997 Dec;33(14):2315-20. doi: 10.1016/s0959-8049(97)00235-9. Eur J Cancer. 1997. PMID: 9616274
[Leukemia and pre-leukemic conditions occurring after treatment of breast cancer].
Cutuli B, Janvier M, de la Rochefordière A, Julien JP, Isambert N, Alzieu C, Kerbrat P, de Lafontan B, van Lemmens L, Curé H, Ganem G, Baume D, Le Mevel A, Lorthoraly A, de Gislain C, Marchal C, Chevelle C, Lauche H, Serin D. Cutuli B, et al. Among authors: de la rochefordiere a, de lafontan b, de gislain c. Presse Med. 2000 Jan 29;29(3):135-8. Presse Med. 2000. PMID: 10686962 Clinical Trial. French.
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H, Lasset C, Bonadona V, Lesur A, Luporsi E, Rodier JF, Cutuli B, Lasry S, Mauriac L, Granon C, Kerr C, Giard S, Hill C, de Lafontan B, de Gislain C, D'Anjou J, Fondrinier E, Lefeuvre C, Parache RM, Chauvin F. Mignotte H, et al. Among authors: de lafontan b, de gislain c. Int J Cancer. 1998 May 4;76(3):325-30. doi: 10.1002/(sici)1097-0215(19980504)76:3<325::aid-ijc7>3.0.co;2-x. Int J Cancer. 1998. PMID: 9579567
52 results